Clinical Trial Update: Pharmacokinetics and Safety of DolutegravIr in Neonate [Phase 1, Phase 2]

View source ↗

Summary

A phased pharmacokinetics and safety trial of dolutegravir in neonates investigating early-life drug exposure and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: Desmond Tutu TB Centre | Conditions: Hiv | Phase 1, Phase 2 | Status: UNKNOWN